NB
Neil Bifulco
Director Of Medicinal Chemistry At Recludix Pharma at Recludix Pharma
View Neil's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Mar 2020 - Present · 4 years and 9 months
Director Of Medicinal Chemistry At Recludix Pharma
Sep 2022 - Present · 2 years and 3 months
Associate Director Of Medicinal Chemistry
Mar 2020 - Sep 2022 · 2 years and 6 months
Senior Scientist Ii
Jun 2018 - Mar 2020 · 1 years and 9 months
Company Details
2-10 Employees
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom generated DNA-encoded libraries, massively parallel determination of structure activity relationships, and a proprietary screening tool to ensure selectivity. Recludix is employing this approach first in the development of SH2 domain inhibitors. Its most advanced programs are focused on Signal Transducer and Activator of Transcription (STAT) proteins -- STAT3 and STAT6 -- where abnormal activation is found in numerous cancer types, such as multiple leukemias and lymphomas, as well as inflammatory diseases, such as rheumatoid arthritis, asthma, atopic dermatitis inflammatory bowel disease, and others. The company is advancing another program with an undisclosed non-STAT SH2 domain target that also plays a significant role in both cancer and autoimmune diseases. For more information, please visit the company’s website at https://recludixpharma.com.
Year Founded
2019
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Greater San Diego Area,West Coast,Western US
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Neil Bifulco in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.